- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- June 2023
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- August 2023
- 266 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- September 2024
- 280 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- December 2023
- 250 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- October 2022
- 160 Pages
Global
From €3407EUR$3,570USD£2,855GBP
The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more